<DOC>
	<DOCNO>NCT01259388</DOCNO>
	<brief_summary>The purpose study determine whether lithium carbonate safe , well-tolerated , effective treat progressive form multiple sclerosis .</brief_summary>
	<brief_title>A Pilot Study Lithium Progressive Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Diagnosis progressive subtype multiple sclerosis revise 2005 McDonald Criteria . EDSS 3.06.5 Ages 3065 Must mentally capable provide informed consent follow study guideline . Relapse steroid treatment within 1 month trial entry . Any current previous treatment mitoxantrone , azathioprine , methotrexate , mycophenolate , cyclophosphamide , experimental therapy . Women pregnant , wish become pregnant come 30 month , breastfeed . Sexually active woman unwilling use reliable contraception ( oral contraceptive , condom , IUD ) . Patients know kidney dysfunction creatinine &gt; 1.4 ; know cardiac arrhythmia significant conduction abnormality EKG ; uncontrolled thyroid disease TSH &gt; 20 % upper limit normal ; uncontrolled psoriasis , HIV , severe medical condition . Patients history unstable psychiatric illness active severe depression . Patients history seizure . Concurrent use follow medication : Antipsychotics , diuretic , digoxin , iodide salt . Use nonsteroidal antiinflammatory drug ( NSAIDs ) 5 day week . Patients history substance abuse past year . Patients sensitive gadolinium , unable undergo require number MRI scan . Unable speak understand sufficient English consent complete study procedure . Patients unable unwilling provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Lithium</keyword>
</DOC>